NoBsRx review
Priced openly, dosed vaguely
The pricing page carries two tiers, and $140 buys the low-dose one: the standard injectable semaglutide program is $179 and the standard injectable tirzepatide program is $249.
Our verdict
NoBsRx publishes every program price on one page, states that the figure shown is the ongoing rate rather than an introductory one, and commits in writing to no dose-based price changes. That is the plain speaking the name promises, and on price it is real. The gap is dose. The page's own control toggles Microdosing against Macrodosing and labels a whole tier Low-Dose without printing a single milligram figure, so a buyer can learn exactly what a program costs and cannot learn how much drug it delivers.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- From
- $179/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Red Rock Compounding
- Updated
- September 2026
What it is
A telehealth service selling six GLP-1 programs — injectable semaglutide, oral semaglutide and injectable tirzepatide, each in a standard and a low-dose version — sold monthly or as a prepaid block of weeks.
How it works
Prescription-gated telehealth. A licensed provider reviews the intake before any prescription, and fulfillment runs through state-licensed 503A compounding pharmacies that the site describes but does not name. No state list is published.
Pricing transparency
Standard programs run $179 a month for injectable semaglutide, $199 for oral semaglutide and $249 for injectable tirzepatide. The low-dose programs run $140, $179 and $140. Prepaid blocks are offered at 12, 24 and 52 weeks. Twelve weeks is 84 days, or 2.76 months, so the $499 block on standard injectable semaglutide works out to about $181 a month against a $179 monthly rate.
Branded vs compounded
Compounded semaglutide and compounded tirzepatide, injectable and oral. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. The site states that its partner pharmacies use pharmaceutical-grade active ingredients carrying a certificate of analysis, and that it does not sell research-use peptides.
Pros and watch-outs
What we like
- All six program prices sit on one page before an intake
- Stated as the ongoing rate, not a first-month rate
- No dose-based price changes, printed on every program card
- Standard and low-dose tiers are labeled separately rather than blended
Watch-outs
- No milligram strength is published for any program
- At $409 the low-dose block works out above the $140 monthly rate
- The compounding pharmacy is not named
- No state list is published
Best for
Buyers who want every tier and term priced before starting an intake.
Who should look elsewhere
Anyone who needs the milligram strength before comparing a price.
How NoBsRx compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A tirzepatide price you can check
See SkinnyRx → - Shed
Compounded pricing without a membership
See Shed → - RxSpan MD
Comparing plan terms upfront
See RxSpan MD →
More GLP-1 sellers by price reviews: HersHeva HealthHimsIdgie HealthImmortalsIndependent Wellness
Evidence & trials · Last updated September 2026
How we assessed this. This review reflects GLP Loss’s own read of NoBsRx’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does the No BS name hold up?
- On price, yes. Six programs carry published monthly figures, prepaid terms are listed beside them, and the page states outright that the figure shown is the ongoing rate rather than an introductory one. On dose it does not hold up: a page that toggles Microdosing against Macrodosing prints no milligram strength for either.
- Is NoBsRx $140 a month?
- That is the low-dose tier. The standard injectable semaglutide program is $179 a month, the standard oral is $199, and the standard injectable tirzepatide is $249. By the site's own labeling the low-dose programs deliver less drug than the standard ones, so the two figures are not describing the same thing.
- Is the prepaid block cheaper than paying monthly?
- Only on some lines. Twelve weeks is 84 days, which is 2.76 months rather than three, so the $409 low-dose block works out to about $148 a month against a $140 monthly rate. The 52-week block does save: $1,899 on standard injectable semaglutide is about $159 a month against $179.
- Does the price rise as the dose climbs?
- No. Every program card carries the line 'No dose-based price changes', and the site names dose-based surprises as one of the practices it was built against. Across a year that commitment is usually worth more than a small gap in the headline figure, because a seller that meters by dose raises the bill exactly when a patient is escalating.
- Is NoBsRx expensive compared with other GLP-1 providers?
- NoBsRx is listed from $179/mo in this comparison. The 387 reviewed GLP-1 providers with a listed monthly starting amount range from $76 to $1299, with a median of $179. That puts NoBsRx at the median. The comparison excludes 192 other reviewed GLP-1 providers. Medicines, doses and payment commitments differ. Confirm the medication, renewal charge and included visits, supplies and delivery before deciding.